Sen. Hatch prefers "incremental" approach to FDA reform; Rep. Barton calls for legislation.
This article was originally published in The Tan Sheet
Executive Summary
SEN. HATCH PREFERS "INCREMENTAL" APPROACH TO FDA REFORM, Patricia Knight, health director for the Utah Republican, told a Medical Device Manufacturers Association meeting May 12 in Washington, D.C. Discussing FDA reform initiatives under way on Capitol Hill, Knight maintained that "large proposals don't have as much of a chance as small proposals...in part because of so many competing interests. Incremental reforms may have more of a chance."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning